This month The Pharmacologist features ASPET’s 2024–2025 Washington Fellows written policy briefs. The Washington Fellows Program is dedicated to enabling developing and early-career scientists interested in science policy to learn about and become more engaged in public policy issues. As part of the program, the Fellows gain skills in writing policy briefs on topics that are of importance to each Fellow. In these briefs, the Fellows showcase compelling arguments for policy improvements on their issue choice.
Summaries are below, followed by links to read each policy brief.
Protecting college athletes from opioid misuse: A policy proposal for education and mental health screening reform in the NCAA
By Brittany Pate, PhD, Emory University School of Medicine
Executive Summary
College athletes are at increased risk for opioid misuse due to high injury rates, pressure to perform, cultural stigma surrounding mental health, and limited awareness of addiction risks (Knettel, Cherenack and Bianchi-Rossi). While the National Collegiate Athletic Association (NCAA) has taken steps to raise awareness about substance use, enforceable nationwide standards for opioid education and behavioral health screening are lacking. This policy brief is directed to Congress, which holds the legislative and funding authority necessary to implement standardized prevention programs across all federally funded institutions. Specifically, this brief outlines two cost-effective, evidence-based interventions Congress can support through federal incentives and oversight:
- Mandatory opioid education programs tailored for NCAA athletes and athletic personnel.
- Annual mental health and addiction risk screenings integrated into standard medical evaluations.
The NCAA represents a key stakeholder in implementation of these interventions, given its operational role in college sports, but Congressional action is critical to ensure consistent, enforceable adoption nationwide. Policy makers can take a leadership role in encouraging adoption of these reforms by leveraging federal grants, student wellness funding, and reporting requirements tied to Higher Education Act provisions. These low-cost, high-impact reforms align with public health best practices and could help prevent addiction before it starts, thereby protecting athletes’ health, careers, and lives.
Breathing Unequally: Confronting Asthma Disparities in Detroit’s Historically Black Neighborhoods
By Elena Levi-D’Ancona, PhD, University of Michigan
Elena is now a Science Policy Fellow at Friends of Cancer Research
Executive Summary



- Partner with Black-led organizations and academic institutions.
- Expand and fund mobile care units with environmental health services.
- Establish a citywide asthma data-sharing initiative.
These actions can reduce health disparities, build community trust, and deliver care where it’s needed most.
Ethylene Oxide: Risk Assessment and Proposed Interventions in Puerto Rico
By Pablo Reina-Gonzalez, University of Rochester School of Medicine and Dentistry
Executive Summary



This policy brief recommends:
- Strengthening emissions regulations by mandating continuous third-party air quality monitoring with real-time public reporting.
- Enhancing public health protections through subsidized health screenings and epidemiological studies.
- Promoting community engagement via public education forums.
Robust, enforceable standards—supported by transparency and community involvement—are vital to reducing EtO exposure and protecting the health of Puerto Rico’s vulnerable communities.
Potential Health Risks of Micro- and Nanoplastics and Proposed Strategies to Reduce Harm
By Kari Gaither, PhD, Washington State University
Executive Summary



Feeding Inequality: How Chicago’s Segregated Past Shapes Food Access Today
By Harshita Kondeti, Loyola University Chicago
Executive Summary



Healthcare Disparities and Improving Access to Care in Rural Appalachia
By Helen Ibeawuchi, MD, University of Pikeville
Executive Summary



Expanding Health Equity in CDBG-Funded Research in Cleveland
By Amanda Ifft, Cleveland State University
Executive Summary



Cleveland’s current CDBG policies do not require demographic data collection or equity assessments for projects, limiting evaluation of whether initiatives reduce disparities. To address this, the city should pass legislation modernizing CDBG use by mandating demographic reporting, requiring annual Equity Impact Assessments (EIAs), and funding mobile health clinics that deliver care and collect data in underserved areas.
Oversight should be integrated into existing advisory boards, and funds should support equity-focused training for researchers and nonprofits. These reforms will improve representation in research, strengthen public health strategies, and ensure investments serve those most affected by systemic inequities. By aligning CDBG use with health equity goals, Cleveland can maximize federal investment and set an example for inclusive, evidence-based public health policy.
Rethinking Mentorship in Graduate School: Why Student Voices Should Shape Faculty Promotions
By Victoria Salemme, University of California, Davis
Executive Summary



Protecting Patients from Counterfeit GLP-1 Drugs: Closing the Gaps in Access, Oversight,
and Awareness
By Sumaih Zoubi, Texas Tech University Health Sciences Center
Executive Summary



According to the FDA, counterfeit Ozempic products have entered the U.S. drug supply chain bearing fake lot numbers and non-sterile needles, posing significant safety risks to patients. The rise of social media advertisements and online telehealth platforms has further facilitated the distribution of these products. In fact, a recent report revealed that between 2023 and early 2025, over 900 adverse events and at least 18 deaths were linked to compounded GLP-1 drugs, including semaglutide and tirzepatide, highlighting the growing severity of the threat. The World Health Organization (WHO) has also issued global warnings urging caution over the rise in falsified GLP-1 products due to their health risks and widespread market infiltration.
To address this growing public health threat, this brief presents five policy recommendations:
- Enforce stricter action against illegal online drug sales.
- Improve accountability on social media and e-commerce platforms.
- Launch a national public education campaign.
- Expand insurance coverage to reduce demand for unsafe alternatives.
- Strengthen guidance and oversight for healthcare providers and compounding pharmacies.

